Small-molecule screen reveals pathways that regulate C4 secretion in stem cell-derived astrocytes

[1]  W. Romero-Fernández,et al.  CRISPRi screens in human astrocytes elucidate regulators of distinct inflammatory reactive states , 2021, bioRxiv.

[2]  Carlos A. Tristan,et al.  Directed Differentiation of Human Pluripotent Stem Cells into Radial Glia and Astrocytes Bypasses Neurogenesis , 2021, bioRxiv.

[3]  D. Pe’er,et al.  Fully defined human pluripotent stem cell-derived microglia and tri-culture system model C3 production in Alzheimer’s disease , 2021, Nature Neuroscience.

[4]  K. H. Utami,et al.  Generation of the Human Pluripotent Stem-Cell-Derived Astrocyte Model with Forebrain Identity , 2021, Brain sciences.

[5]  Christopher W. Whelan,et al.  Overexpression of schizophrenia susceptibility factor human complement C4A promotes excessive synaptic loss and behavioral changes in mice , 2020, Nature Neuroscience.

[6]  M. Leboyer,et al.  Overexpression of complement component C4 in the dorsolateral prefrontal cortex, parietal cortex, superior temporal gyrus and associative striatum of patients with schizophrenia , 2020, Brain, Behavior, and Immunity.

[7]  Bin Zhang,et al.  CD49f Is a Novel Marker of Functional and Reactive Human iPSC-Derived Astrocytes , 2020, Neuron.

[8]  O. Reiner,et al.  Complement System in Brain Architecture and Neurodevelopmental Disorders , 2020, Frontiers in Neuroscience.

[9]  Thomas M. Durcan,et al.  Characterization of human iPSC-derived astrocytes with potential for disease modeling and drug discovery , 2019, Neuroscience Letters.

[10]  K. Bae,et al.  Rapid differentiation of astrocytes from human embryonic stem cells , 2019, Neuroscience Letters.

[11]  Gary D. Bader,et al.  Single-cell transcriptomic profiling of the aging mouse brain , 2019, Nature Neuroscience.

[12]  C. Le Magueresse,et al.  Emerging Roles of Complement in Psychiatric Disorders , 2019, Front. Psychiatry.

[13]  Allan R. Jones,et al.  Conserved cell types with divergent features in human versus mouse cortex , 2019, Nature.

[14]  Melanie A. Huntley,et al.  Complement C3 Is Activated in Human AD Brain and Is Required for Neurodegeneration in Mouse Models of Amyloidosis and Tauopathy. , 2019, Cell reports.

[15]  Richard Reynolds,et al.  Neuronal vulnerability and multilineage diversity in multiple sclerosis , 2019, Nature.

[16]  A. Cruz-Martín,et al.  Increased expression of schizophrenia-associated gene C4 leads to hypoconnectivity of prefrontal cortex and reduced social interaction , 2019, bioRxiv.

[17]  R. Perlis,et al.  Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning , 2019, Nature Neuroscience.

[18]  Melanie A. Huntley,et al.  Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies , 2018, Neuron.

[19]  H. Zetterberg,et al.  Human iPS-Derived Astroglia from a Stable Neural Precursor State Show Improved Functionality Compared with Conventional Astrocytic Models , 2018, Stem cell reports.

[20]  A. Fischer,et al.  The BET/BRD inhibitor JQ1 improves brain plasticity in WT and APP mice , 2017, Translational Psychiatry.

[21]  Spyros Darmanis,et al.  Human Astrocyte Maturation Captured in 3D Cerebral Cortical Spheroids Derived from Pluripotent Stem Cells , 2017, Neuron.

[22]  Galina A. Erikson,et al.  Stem Cell Reports Resource Differentiation of Inflammation-Responsive Astrocytes fromGlial Progenitors Generated from Human Induced Pluripotent Stem Cells , 2017 .

[23]  Angela N. Brooks,et al.  A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles , 2017, Cell.

[24]  K. Brennand,et al.  An Efficient Platform for Astrocyte Differentiation from Human Induced Pluripotent Stem Cells , 2017, bioRxiv.

[25]  Jacob K. Asiedu,et al.  The Drug Repurposing Hub: a next-generation drug library and information resource , 2017, Nature Medicine.

[26]  J. Nascimento,et al.  Derivation of Functional Human Astrocytes from Cerebral Organoids , 2017, Scientific Reports.

[27]  Manoj Kumar,et al.  INGE GRUNDKE-IQBAL AWARD FOR ALZHEIMER’S RESEARCH: NEUROTOXIC REACTIVE ASTROCYTES ARE INDUCED BY ACTIVATED MICROGLIA , 2019, Alzheimer's & Dementia.

[28]  R. Perlis,et al.  Patient-specific models of microglia-mediated engulfment of synapses and neural progenitors , 2016, Molecular psychiatry.

[29]  G. Sartor,et al.  The BET-Bromodomain Inhibitor JQ1 Reduces Inflammation and Tau Phosphorylation at Ser396 in the Brain of the 3xTg Model of Alzheimer’s Disease , 2016, Current Alzheimer research.

[30]  Lee L. Rubin,et al.  Large-Scale Production of Mature Neurons from Human Pluripotent Stem Cells in a Three-Dimensional Suspension Culture System , 2016, Stem cell reports.

[31]  John D Lambris,et al.  New milestones ahead in complement-targeted therapy. , 2016, Seminars in immunology.

[32]  Ben A. Barres,et al.  Complement and microglia mediate early synapse loss in Alzheimer mouse models , 2016, Science.

[33]  Giulio Genovese,et al.  Schizophrenia risk from complex variation of complement component 4 , 2016, Nature.

[34]  M. Missler,et al.  Rapid and robust generation of long-term self-renewing human neural stem cells with the ability to generate mature astroglia , 2015, Scientific Reports.

[35]  P. Bork,et al.  Histone Deacetylase Inhibitors (HDACi) Cause the Selective Depletion of Bromodomain Containing Proteins (BCPs)* , 2015, Molecular & Cellular Proteomics.

[36]  G. Taglialatela,et al.  NFκB-Activated Astroglial Release of Complement C3 Compromises Neuronal Morphology and Function Associated with Alzheimer’s Disease , 2015, Neuron.

[37]  C. Spencer,et al.  Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.

[38]  Zhoulei Li,et al.  BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphoma , 2014, Proceedings of the National Academy of Sciences.

[39]  J. Satoh,et al.  Human Astrocytes: Secretome Profiles of Cytokines and Chemokines , 2014, PloS one.

[40]  Lesley S. Chaboub,et al.  Astrocyte form and function in the developing central nervous system. , 2013, Seminars in pediatric neurology.

[41]  T. Gasser,et al.  Combined Flow Cytometric Analysis of Surface and Intracellular Antigens Reveals Surface Molecule Markers of Human Neuropoiesis , 2013, PloS one.

[42]  H. Kinney,et al.  Expression of EAAT2 in neurons and protoplasmic astrocytes during human cortical development , 2012, The Journal of comparative neurology.

[43]  I. Germano,et al.  Efficient differentiation of human embryonic and induced pluripotent stem cells into functional astrocytes. , 2012, Stem cells and development.

[44]  Yan Liu,et al.  Specification of transplantable astroglial subtypes from human pluripotent stem cells , 2011, Nature Biotechnology.

[45]  Jau-Shyong Hong,et al.  Transcriptional Factor NF-κB as a Target for Therapy in Parkinson's Disease , 2011, Parkinson's disease.

[46]  J. Šteňo,et al.  GFAP-positive astrocytes are rare or absent in primary adult human brain tissue cultures , 2009, Biologia.

[47]  Christian Steinhäuser,et al.  Astrocyte dysfunction in neurological disorders: a molecular perspective , 2006, Nature Reviews Neuroscience.

[48]  J. Rapoport,et al.  Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Y. Fujiyama,et al.  Sodium butyrate blocks interferon‐gamma (IFN‐γ)‐induced biosynthesis of MHC class III gene products (complement C4 and factor B) in human fetal intestinal epithelial cells , 1999, Clinical and experimental immunology.

[50]  D. Walker,et al.  Expression of complement C4 and C9 genes by human astrocytes , 1998, Brain Research.

[51]  P. Gasque,et al.  Extrahepatic complement biosynthesis: where, when and why? , 1997, Clinical and experimental immunology.

[52]  M. Walport,et al.  IFN-gamma up-regulates expression of the complement components C3 and C4 by stabilization of mRNA. , 1996, Journal of immunology.

[53]  P. Gasque,et al.  Complement expression in human brain. Biosynthesis of terminal pathway components and regulators in human glial cells and cell lines. , 1995, Journal of immunology.

[54]  D. Gordon,et al.  Detection of complement protein mRNA in human astrocytes by the polymerase chain reaction , 1992, Journal of Neuroscience Methods.

[55]  M. Carroll,et al.  Substitution of a single amino acid (aspartic acid for histidine) converts the functional activity of human complement C4B to C4A. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Wen-chao Song,et al.  Complement and its role in innate and adaptive immune responses , 2010, Cell Research.

[57]  D. Lewis,et al.  Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. , 2000, Archives of general psychiatry.

[58]  S. Barnum.  Complement biosynthesis in the central nervous system. , 1995, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.